Winthrop Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Winthrop Capital Management's AMGN Position: Q2 2026 in Review
Winthrop Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 19 shares — an estimated $7K sold.
Winthrop Capital Management first reported a position in AMGN in Q2 2024 and held it in 6 quarters. The position peaked at $318K in Q3 2024. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Winthrop Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Winthrop Capital Management sold 19 Amgen shares in Q2 2026, an estimated $7K.
- Winthrop Capital Management first reported a position in Amgen in Q2 2024 and held it in 6 quarters.
- Winthrop Capital Management's Amgen position peaked at $318K in Q3 2024.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.